Prospective Determination of Orbital Perfusion Dominance before Intra-Arterial Chemotherapy for Retinoblastoma Using Time-of-Flight Magnetic Resonance Angiography
Authors:
Open Access
- 4 March 2022
- journal article
- research article
- Published by Georg Thieme Verlag KG in Journal of Clinical Interventional Radiology ISVIR
- Vol. 07 (01) , 064-068
Abstract
Intra-arterial chemotherapy (IAC) represents a mainstay in the treatment of retinoblastoma. In a minority of cases, the external carotid artery (ECA) serves as the dominant supply to the central retinal artery and is associated with prolonged fluoroscopy times and higher intraprocedural radiation doses. The aim of this study was to evaluate the utility of time-of-flight (TOF) magnetic resonance angiography (MRA) for prospective determination of internal (ICA) versus ECA dominance for procedural planning. Between April 2017 and December 2020 (44 months), staging MR prior to IAC for retinoblastoma included variant spatial saturation band position TOF angiography. Exams were then retrospectively reviewed for concordance of ICA versus ECA dominance between the two modalities. Eight consecutive patients were included in the study. Mean patient age at time of diagnosis was 20.3 ± 10.7 months (range: 2.7–33.2 months). Ten affected eyes were included (2 cases of bilateral disease), with stage D disease in eight eyes and stage B disease in two eyes. MRA techniques demonstrated antegrade ophthalmic artery (OA) flow in 9/10 (90%) of affected eyes. Subsequent catheter angiography confirmed ICA dominant supply in 9/9 (100%). For a single affected eye (10%), the OA was demonstrated as orthotopic by T2 flow void, nonvisualized on anterior saturation TOF sequences, and faintly visualized on posterior saturation TOF sequences. Aggregate MRA to catheter angiographic concordance was 10/10 (100%). Variant saturation TOF MRA predicts ICA versus ECA dominant supply to the central retinal artery in retinoblastoma.Keywords
This publication has 10 references indexed in Scilit:
- Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocolsPediatric Radiology, 2020
- Intra-arterial chemotherapy for retinoblastoma: the dosimetric impactNeuroradiology, 2019
- Technical and anatomical factors affecting intra-arterial chemotherapy fluoroscopy time and radiation dose for intraocular retinoblastomaJournal of NeuroInterventional Surgery, 2019
- Hemodynamic and Anatomic Variations Require an Adaptable Approach during Intra-Arterial Chemotherapy for Intraocular Retinoblastoma: Alternative Routes, Strategies, and Follow-UpAmerican Journal of Neuroradiology, 2016
- A review of the literature for intra-arterial chemotherapy used to treat retinoblastomaPediatric Radiology, 2016
- Transorbital anastomotic pathways between the external and internal carotid systems in children affected by intraocular retinoblastomaSurgical and Radiologic Anatomy, 2015
- Radiation-sensitive genetically susceptible pediatric sub-populationsPediatric Radiology, 2008
- MR Pulse Sequences: What Every Radiologist Wants to Know but Is Afraid to AskRadioGraphics, 2006
- Second primary tumors in hereditary retinoblastoma: a register-based study, 1945–1997Ophthalmology, 2001
- Second primary neoplasms in patients with retinoblastomaBritish Journal of Cancer, 1986